City Therapeutics, Inc. (CTY)

NASDAQ: CTY · Real-Time Price · USD

18.25

+1.18 (6.91%)

Nov 6, 2026, 4:00 PM EST - Market closed

City Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Nov '26 Nov 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Market Capitalization	908	-	-
Market Cap Growth	-	-	-
Enterprise Value	795	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Nov '26 Nov 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Debt / Equity Ratio	0.46	1.12	0.19
Net Debt / Equity Ratio	-0.90	-0.76	-0.91
Net Debt / EBITDA Ratio	1.36	0.78	3.65
Net Debt / FCF Ratio	1.39	1.03	4.37
Asset Turnover	-	0.09	-
Quick Ratio	2.70	3.00	6.18
Current Ratio	2.71	3.07	6.22
Return on Equity (ROE)	-	-66.88%	-
Return on Assets (ROA)	-	-25.38%	-
Return on Capital Employed (ROCE)	-58.70%	-53.60%	-23.30%

Yields

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Nov '26 Nov 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Buyback Yield / Dilution	-	-37.97%	-

SEC Filings: 10-K · 10-Q